Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.85 USD | -0.20% | +7.20% | +6.78% |
05-14 | Transcript : Belite Bio, Inc, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Belite Bio, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.78% | 1.46B | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+37.07% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- BLTE Stock
- News Belite Bio, Inc
- Belite Bio Says It Received Chinese Regulatory Approval to Begin Phase 3 Trial of LBS-008 to Treat Eye Disease